These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30644586)

  • 1. Vasoactive Agent Use in Septic Shock: Beyond First-Line Recommendations.
    Sacha GL; Bauer SR; Lat I
    Pharmacotherapy; 2019 Mar; 39(3):369-381. PubMed ID: 30644586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.
    Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Laderchi A; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
    Crit Care; 2008; 12(6):R143. PubMed ID: 19017409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
    Nguyen HB; Lu S; Possagnoli I; Stokes P
    J Intensive Care Med; 2017 Aug; 32(7):451-459. PubMed ID: 27189952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL; Walley KR
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock.
    Kampmeier TG; Arnemann PH; Hessler M; Seidel LM; Becker K; Morelli A; Rehberg SW; Ertmer C
    Sci Rep; 2018 May; 8(1):7105. PubMed ID: 29740065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal norepinephrine-equivalent dose to initiate epinephrine in patients with septic shock.
    Ammar MA; Limberg EC; Lam SW; Ammar AA; Sacha GL; Reddy AJ; Bauer SR
    J Crit Care; 2019 Oct; 53():69-74. PubMed ID: 31202160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of obesity on safety and efficacy of weight-based norepinephrine dosing in septic shock: A single-center, retrospective study.
    Wong PJ; Pandya KA; Flannery AH
    Intensive Crit Care Nurs; 2017 Aug; 41():104-108. PubMed ID: 28343834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
    Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on "A comparison of epinephrine and norepinephrine in critically Ill patients".
    Oud L
    Intensive Care Med; 2009 Jul; 35(7):1310; author reply 1311. PubMed ID: 19367392
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
    Silverstein DC; Beer KA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(1):48-54. PubMed ID: 25655726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressors to treat refractory septic shock.
    Meresse Z; Medam S; Mathieu C; Duclos G; Vincent JL; Leone M
    Minerva Anestesiol; 2020 May; 86(5):537-545. PubMed ID: 31994366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.